跳至主要内容
临床试验/CTRI/2019/05/019423
CTRI/2019/05/019423招募中3 期

Randomized Controlled Clinical Trial to Evaluate the Efficacy of Amrutadi Yog in Essential Hypertension

il0 个研究点目标入组 240 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Newly diagnosed patients of stage 1 essential hypertension with blood pressure systolic blood pressure is equal to and more than 140 mmHg and less than 160 mmHg and diastolic blood pressure is equal to and more than 90 mmHg and less than 100 mmHg

排除标准

  • 1.Patients receiving anti-hypertensive drug.
  • 2.Complicated hypertensive cases.
  • Known case of Nephropathy, Left Ventricular Hypertrophy, heart block, Congestive Cardiac Failure, Coronary Artery Disease and retinopathy. Patients suffering from Diabetes Mellitus and severe other illness like hepatic or renal failure.
  • 3.Secondary, Accelerated and Malignant Hypertension
  • 4.Patients taking steroids, oral contraceptive pills, estrogen replacement therapy or NSAIDS group of drug
  • 5.Pregnant women or planning pregnancy within six months.

研究者

发起方
il

相似试验